---
title: ANDEXANET ALFA VS NON-SPECIFIC TREATMENTS FOR INTRACEREBRAL HEMORRHAGE IN PATIENTS
  TAKING FACTOR XA INHIBITORS - INDIVIDUAL PATIENT DATA ANALYSIS OF ANNEXA-4 AND TICH-NOAC
date: '2024-01-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38264861/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240124170612&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Use of andexanet alfa compared to any other non-specific
  treatment strategy was associated with decreased odds for hematoma expansion, without
  increased odds for thromboembolic ...'
disable_comments: true
---
CONCLUSIONS: Use of andexanet alfa compared to any other non-specific treatment strategy was associated with decreased odds for hematoma expansion, without increased odds for thromboembolic ...